These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 20146695)

  • 1. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
    Mammen AL
    Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
    Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
    Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MRI in the assessment of polymyositis and dermatomyositis.
    Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J
    Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The geoepidemiology of autoimmune muscle disease.
    Prieto S; Grau JM
    Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune manifestations of inflammatory muscle disease.
    Targoff IN
    Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myositis-specific autoantibodies and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dermatomyositis and polymyositis].
    Pellissier JF; Civatte M; Fernandez C; Bartoli C; Chetaille B; Schleinitz N; Figarella-Branger D
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):934-47. PubMed ID: 12407302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
    Sarkar K; Weinberg CR; Oddis CV; Medsger TA; Plotz PH; Reveille JD; Arnett FC; Targoff IN; Genth E; Love LA; Miller FW
    Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
    Venalis P; Lundberg IE
    Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.
    Pinal-Fernandez I; Casciola-Rosen LA; Christopher-Stine L; Corse AM; Mammen AL
    J Rheumatol; 2015 Aug; 42(8):1448-54. PubMed ID: 26443871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory diagnostics of polymyositis/dermatomyositis].
    Prus V; Bedeković D
    Reumatizam; 2012; 59(2):27-30. PubMed ID: 23745451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].
    Li Q; Lu BX; Zhou L; An SL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1139-40. PubMed ID: 12480599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatomyositis and polymyositis: new treatment targets on the horizon.
    Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
    Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.